Ampio Pharmaceuticals, Inc.
Ampio Pharmaceuticals, Inc. is grouped at the issuer level across 1 linked ticker lifecycle, combining public listing, delisting, source, and shareholder outcome records from the archive.
Lifecycle Map
Issuer enters the archive
Oct 25, 2007Ampio Pharmaceuticals, Inc. is represented as an issuer-level entity with 1 linked public-market ticker lifecycle.
Delisting event
Apr 4, 2024Removed from listing - SEC Form 25 filed.
SourceAMPE stopped trading
Apr 4, 2024AMPE is linked to Ampio Pharmaceuticals, Inc. and ended with final status "bankrupt".
Source
Entity Graph
Ampio Pharmaceuticals, Inc.issuedAMPE
AMPElisted onAMEX
AMPEresulted inwiped out
Source-Backed Claims
- On January 21, 2025, the District Court, City & County of Denver, State of Colorado, issued a Preliminary Approval Order for a proposed settlement of three stockholder derivative actions and two demands related to the results of the Company’s AP-013 trial for Ampion.8-K
- The proposed settlement was entered into through a stipulation and agreement of settlement dated January 8, 2025, among multiple plaintiffs and the Company as a nominal defendant.8-K
- A hearing is scheduled for April 7, 2025, at 10:00 a.m. MDT to determine final approval of the proposed settlement.8-K
- On August 16, 2024, the Company was dissolved in accordance with Section 278 of the Delaware General Corporation Law, existing solely for legal defenses and liability discharges.8-K
- The filing of this Current Report on Form 8-K was made solely to comply with the Preliminary Approval Order.8-K
- Exhibits attached to the Current Report on Form 8-K include the Stipulation and Agreement of Settlement and the Notice of Proposed Derivative Settlement dated January 21, 2025.8-K
Associated Tickers
Public-market security lifecycles tied to this issuer record.